# Peter Van Gelderen

> Peter Van Gelderen is a venture - series unknown investor at ICOS Capital Management backing Biotechnology. See 6 investments, check sizes, portfolio…

- Type: Angel Investor
- Fund: [ICOS Capital Management](https://shizune.co/investors/profile/icoscapital)
- Location: Amsterdam, The Netherlands
- Total investments: 6
- Last investment: Apr 2026
- Lead investor: 67%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/peter-van-gelderen-0132703/

Peter Van Gelderen is a venture - series unknown investor at ICOS Capital Management in Amsterdam focused on Biotechnology and Carbon Capture. Peter Van Gelderen - Chief Investment Officer and Partner @ ICOS Capital Management

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 33% |
| Carbon Capture | 2 | 33% |
| Wellness | 1 | 17% |
| CleanTech | 1 | 17% |
| GreenTech | 1 | 17% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Venture - Series Unknown | 2 | 33% |
| Seed | 1 | 17% |
| Series A | 1 | 17% |
| Series B | 1 | 17% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 1 | 17% |
| Poland | 1 | 17% |
| United States | 1 | 17% |
| United Kingdom | 1 | 17% |
| The Netherlands | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Foamlab | FoamLab specializes in high-performance, bio-based foams made from bacterial nanocellulose and develops a new class of sustainable foams made from bacterial cellulose, a natural and renewable material grown through fermentation. | $3.5M | Seed | Apr 23, 2026 |  |
| Abolis Biotechnologies | Abolis is a French company delivering high-impact innovations in biotechnologies that supports industries in their transition to build a better future in collaboration with Nature. We provide tailor-made industrial solutions based on micro-organisms. Founded in 2014, Abolis is made up of a team of over 54 people, sharing a scientific and humanistambition. Determined to become a key player in the transformation of manufacturing, we combine our expertise in biology, fermentation, IT, robotics, analytics and industrial property to reinvent the future of numerous industries - from food to healthcare, cosmetics and chemicals. We help industries make the ecological transition by rethinking their production models We rely on biotechnologies and the untapped potential of micro-organisms to develop new bioproduction solutions that are economically and ecologically sustainable alternatives to petrochemical products and chemical ingredients. We take up the industry's current challenges by: ·      Using renewable raw materials ·      Relocate essential production and secure supply chains ·      Designing biocompatible products less toxic for the environment ·      Reducing greenhouse gas emissions Abolis is providing tailor-made industrial solutions, based on microorganisms We are… independent in thought and action rigorous in our approach and the way we work creative because we never stop innovating, while remaining pragmatic ambitious because we are passionate and determined to make a difference | $38.8M | Venture - Series Unknown | Sep 12, 2024 |  |
| NapiFeryn BioTech | NapiFeryn BioTech extracts protein from rapeseed oil production waste streams for functional, nutritional, and cost-effective protein isolates and concentrates. These ingredients are a sustainable alternative to animal-derived proteins, are nutritional, and can be used in a wide variety of applications | $2.7M | Venture - Series Unknown | Jan 30, 2023 |  |
| CarbonOrO | CarbonOrO uses a bespoke amine solution to capture CO2 from gasses.The heart of the installation with two main elements: an absorber and a desorber. Both are simple cylindrical vessels. The amine solution is pumped from the absorber to the desorber and back to the absorder in a continuous process.Raw gas (containing CO2) at ambient conditionsenters the bottom of the absorber on the left. The amine solution flows top to bottom, in counterflow with the gas stream, and absorbs the CO2 from the gas. The cleaned gas evaporates at the top of the absorder.The amine solution transports the CO2 to the desorber where it is released by heating. Traditional amine desorbers operate at 120 °C or above; CarbonOrO desorber temperature is as low as 70 °C, saving 10-25% in energy. Moreover, heating can be done with waste heat (condensed steam) that is typically available at low cost in industrial environment. Adequate integration of desorber heating with existing utilities may save up to 50% in energy costs. Carbon capture is done at atmospheric conditions, not requiring any compression of raw gas. | $4.3M | Series A | Dec 21, 2022 |  |
| Carbon Clean Solutions | Carbon Clean Solutions is an innovation company specializing in carbon dioxide (CO2) recovery technology for industrial purposes. CCS APBS breakthrough technology significantly reduces the operating costs and environmental impacts, thereby, making CCS technology cost-effective.Carbon Clean Solutions provides proprietary technology to power plantsand industrial utilities for removing up to 90% carbon dioxide from the flue gases. Patented carbon capture technology developed by Carbon Clean Solutions, involves capturing carbon dioxide using proprietary regenerable advanced solvent combined with improved energy integration CO2 capture process. Low cost, energy-efficient APBS CO2 capture technology can be embedded in new power plants or retrofitted to existing ones.Carbon Clean Solutions operates multiple research teams and facilities across the globe and is commercializing its innovative energy=efficient CO2 capture with global customers. | $8M | Series B | Aug 03, 2021 |  |
| Carbon Clean Solutions | Carbon Clean Solutions is an innovation company specializing in carbon dioxide (CO2) recovery technology for industrial purposes. CCS APBS breakthrough technology significantly reduces the operating costs and environmental impacts, thereby, making CCS technology cost-effective.Carbon Clean Solutions provides proprietary technology to power plantsand industrial utilities for removing up to 90% carbon dioxide from the flue gases. Patented carbon capture technology developed by Carbon Clean Solutions, involves capturing carbon dioxide using proprietary regenerable advanced solvent combined with improved energy integration CO2 capture process. Low cost, energy-efficient APBS CO2 capture technology can be embedded in new power plants or retrofitted to existing ones.Carbon Clean Solutions operates multiple research teams and facilities across the globe and is commercializing its innovative energy=efficient CO2 capture with global customers. | $22M | Series B | Jul 02, 2020 |  |

6 of 6 investments shown.

## Co-investors
- [Equinor Ventures](https://shizune.co/investors/profile/equinor-ventures) — VC Fund, 2 deals together
- [WAVE Equity Partners](https://shizune.co/investors/profile/wave-equity-partners) — VC Fund, 2 deals together
- [BioActor](https://shizune.co/investors/profile/bioactor) — VC Fund, 1 deal together
- [Business Opportunities for L'Oréal Development](https://shizune.co/investors/profile/business-opportunities-for-l-or%C3%A9al-development) — VC Fund, 1 deal together
- [Capricorn Industrial Biotech Fund](https://shizune.co/investors/profile/capricorn-industrial-biotech-fund) — VC Fund, 1 deal together
- [Cemex Ventures](https://shizune.co/investors/profile/cemex-ventures) — VC Fund, 1 deal together

## About ICOS Capital Management

VC Fund · Rotterdam, The Netherlands

ICOS Capital is a professional venture and growth capital investment firm with combined experience of over 50 years of investing over 100 million euros in over 40 European technology companies. It differentiates itself as an operational venture capital firm after having directed numerous success stories, with over 75 years of hands on experienceand 12 exits through M&A and IPOs. It has strategic partnership with major corporations that see value in being at the forefront of the development and dissemination of cleantech innovations, both for capital gains and to substantiates strategic and corporate social responsibility objectives. These strategic alliances provide ICOS Capital with preferred access to the corporations’ extensive global networks and considerable knowledge base.

4 contacts available at ICOS Capital Management.

| Name | Title | Profile |
| --- | --- | --- |
| Peter Van Gelderen | Chief Investment Officer and Partner | https://shizune.co/investors/profile/peter-van-gelderen |
| Fred Van Efferink | Partner | https://shizune.co/investors/profile/fred-van-efferink |
| Nityen Lal | Chief Executive Officer and Managing Director | https://shizune.co/investors/profile/nityen-lal |
| Rudi Dupper | Chief Financial Officer | https://shizune.co/investors/profile/rudi-dupper |

## Similar investors

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund

## FAQ

### What does Peter Van Gelderen invest in?

Peter Van Gelderen invests primarily in Biotechnology, Carbon Capture and Wellness startups, most often at Venture - Series Unknown and Seed stage. Most of the 6 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Peter Van Gelderen last invest?

The most recent investment recorded for Peter Van Gelderen closed in Apr 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co